Perfusion System Market Summary:
According to Transpire Insights, a detailed research report on the market reflects that the Transplant Centers end-user segment dominates the Perfusion System Market, accounting for approximately 68.66% of the total share worldwide in 2025. Medtronic plc leads the market with significant presence and revenue, making it a leading contributor to market development, innovation, advanced perfusion system technologies, expanding product capabilities, and growth dynamics.
Market Snapshot
- Market Value (2025): USD 1.56 Billion.
- Expected Market Value (2026): USD 1.66 Billion.
- Estimated Market Value (2033): USD 2.62 Billion.
- Forecast CAGR (2026–2033): 8.24%.
- Leading Region in 2025: North America
- Second-largest Region: Europe
- Fastest Growing Region: Asia Pacific
Introduction
The perfusion equipment market refers to development, production, and sales of machines that are utilized in delivering water or blood in the circulatory or lymphatic systems of tissues and organs. Examples of such equipment include machines for cardiac and other procedures, which operate for a specific period of time so that organs can function while undergoing surgery and transplantation. Pulsing Equipment refers to a certain type of device or machine that is used in circulation of blood or some other kind of liquid through cells, tissue, or organ systems temporarily substituting the function of heart and lungs. Long-term organ storage the process of machine perfusion is involved when organs of donors are kept in controlled environmental conditions which provides them longer time for preservation and broader opportunities for transportation and transplantation. Control of viability the use of normothermic and hypothermic processes enables healthcare specialists to conduct an assessment of importance and viability of organs prior to the process of transplantation. Cardiopulmonary perfusion heart-lung machines are important in the absence of oxygenation during complicated procedures involving the cardiovascular system. High cell concentrations continuous perfusion bioreactor systems enable conducting high cell density which boosts efficiency. Minimized postoperative complications efficient perfusion leads to significant diminishing of ischemic damage, restoration of graft performance post transplantation.
- For instance: North America dominates the worldwide perfusion system market, with the US serving as the main revenue center due to its large volume of cardiac surgeries, sophisticated transplant facilities, and significant R&D expenditures.
Market Highlights: -
- North America is expected to grow at a rapid CAGR in the Perfusion System Market by holding almost 35% of the share during the forecast period.
- Europe is anticipated to hold almost 20% share of the Perfusion System Market over the predicted timeframe.
- Asia Pacific is anticipated to hold roughly 15% share of the Perfusion System Market over the predicted timeframe.
- By product type, the Oxygenators segment dominated the market and holds nearly 26% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
- By application, the Cardiac Surgery segment dominated the market and holds nearly 42% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
- By end user, the Hospitals segment dominated the market and holds nearly 50% share in 2025 and is projected to grow at a substantial CAGR during the forecast period.
- National Health Missions and Universal Coverage: The various funding and repayment mechanisms, which include Medicare in the United States, help in making access to advanced procedures that include complex cardiovascular surgeries and organ transplantation easier, thus indirectly raising the demand for advanced perfusion equipment. The expansion of healthcare infrastructure and transplant capacity along with reimbursement programs will help boost the adoption rate of perfusion technologies all over the world.
How is Technology Driving Growth in the Perfusion System Market?
The Perfusion System Market is undergoing a transformation with advanced organ preservation technologies, particularly the use of normothermic machine perfusion (NMP) in preserving donor organs under conditions resembling normal body temperature and hypothermic machine perfusion (HMP) that minimizes metabolism while reducing chances of ischemia. Integration of automated systems and AI-enabled monitoring has improved control of data in real time and effective clinical decision-making and personalized perfusion. Furthermore, portable and small-sized perfusion systems provide safe transportation of organs over long distances improving availability of options for transplantation. In pharmaceutical practice, automated technologies in cell perfusion improve transportation of nutrients and waste pulp in the process of producing medicines based on biologics. Finally, technological advancements enhance organ preservation, operational efficiency, effective clinical reliability, and wider adoption of advanced perfusion methods in medicine and pharmacology practices.
|
Report Metrics |
Details |
|
Market size value in 2025 |
USD 1.56 Billion |
|
Market size value in 2026 |
USD 1.66 Billion |
|
Revenue forecast in 2033 |
USD 2.62 Billion |
|
Growth rate |
CAGR of 6.74% from 2026 to 2033 |
|
Base year |
2025 |
|
Historical data |
2021 - 2024 |
|
Forecast period |
2026 - 2033 |
|
Report coverage |
Revenue forecast, competitive landscape, growth factors, and trends |
|
Regional scope |
United States; Canada; Mexico; United Kingdom; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; United Arab Emirates |
|
Key company profiled |
LivaNova, Getinge, Medtronic, Terumo Corporation, Abbott Laboratories, Fresenius Medical Care, Xenios AG, Braile Biomédica, Senko Medical, Nipro Corporation, Eurosets, SynCardia Systems, Spectrum Medical, Chalice Medical, Tianjin Medical |
|
Customization scope |
Free report customization (country, regional & segment scope). Avail customized purchase options to meet your exact research needs. |
|
Report Segmentation |
By Product Type (Heart-Lung Machines, Perfusion Pumps, Oxygenators, Cannulae, Tubing Sets, Perfusion Monitoring Systems, Disposable Perfusion Kits, Others); By Application (Cardiac Surgery, Organ Transplantation, ECMO, Neurovascular Surgery, Liver Surgery, Lung Surgery, Research Applications, Others); By End User (Hospitals, Cardiac Centers, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes, Academic Hospitals, Others); By Technology (Conventional Perfusion, Miniaturized Perfusion Systems, AI-assisted Perfusion, Automated Perfusion Systems, Portable Perfusion Systems, ECMO Integration, Others); By Distribution Channel (Direct Sales, Medical Device Distributors, Hospital Procurement, OEM Supply, Online B2B, Others) |
Market Drivers
Increase Need for Cardiac Procedures Due to increasing prevalence of cardiovascular diseases rising prevalence of cardiovascular diseases has increased the need for cardiac surgical procedures and cardiopulmonary bypass equipment. Increase in organ transplants, rise in the number of people with organ failure and increased volume of organ transplants has initiated the uptake of advanced organ preservation and transportation methods. Move to machine perfusion hypothermic and normothermic machine perfusion has improved viability assessment, preservation, and transplant results. Use of extended-criteria donors the use of perfusion systems made it possible to assess and revive organs from extended-criteria donors which make it possible to increase donor supply. Integration with technology and AI advanced sensors, automatic regulation as well as AI assistance lead to improvements in perfusion procedure execution. Aging populations the growing number of the elderly generates an increase in the prevalence of chronic diseases leading to organ failures and surgeries required for organ transplantation. Extended organ viability refers to the use of ex vivo normothermic machine perfusion, which keeps organs in a process close to physiological norms, preserving organs for more extended periods. Enhanced transplantation success or perfusion devices allows evaluation and correction of less than ideal organs. Intraoperative safety means that automated perfusion devices provide control over fluid delivery, low-pressure monitoring and adjustments, and, thus, safety during surgical procedures. Portability means small-sized and easy-to-use ECMO and other perfusion devices used in emergencies and conditions where fast diagnosis is required.
- For Instance: - Organ transplants and an increase in cardiovascular disorders are driving the growth of the worldwide perfusion system market. Russia's medical device industry is regional and import-restricted, with a concentration on governmental investments in domestic healthcare.
- The Asia-Pacific market for perfusion systems is the fastest-growing in the world due to an increase in organ transplants and cardiovascular disorders, modernizing hospital infrastructure, and increased healthcare investments.
Restrain
High capital and maintenance costs, significant costs associated with equipment, disposables, and maintenance hinder adoption of the technology, especially in the developing healthcare industry. Low availability of skilled professionals and availability of trained perfusionists and technical experts limits the effectiveness of the technology. Rigid regulatory approvals, complex safety approval processes and regulatory processes can complicate bringing the product to market. Ineffective reimbursement policies and insufficient reimbursement of modern perfusion and organ preservation procedures can discourage the healthcare industry from using these technologies.
Analysis of Prices and Consumer Behaviour
In 2025, the hypothermic machine perfusion technology will be dominant in the perfusion systems market with a share of 53.62%, which can be attributed to its growing popularity for organ preservation and transplantation. It can be noted that the advanced perfusion systems tend to be more expensive than traditional technologies due to the fact that they include advanced monitoring, temperature control, circulation, automation, etc. Currently, the perfusion system market can be divided accordingly, as the kidney preservation area will comprise about 37.21% of the perfusion market, which is due to the fact that there is a growing demand for kidney transplants and machine perfusion. As for the transplant center segment, it deserves attention as it is responsible for 68.66% of the market, which shows a high level of advancements in the organ preservation field. According to the market revenue indicators, the purchasing habits of healthcare providers state that 34.55% of the revenue comes from North America because of its advanced medical treatment technologies. Besides, clients value system reliability, good performance, and compliance with regulations, which makes up 33% of the perfusion system market.
Who are the Key Players in the Perfusion System Market and how do they compete?
Competitiveness on the international market of perfusion systems involves companies specializing in the technologies of organ preservation, cardiopulmonary support systems, bioprocessing, and development of technologies for specific health care purposes. The companies compete not only in terms of price but also technology-wise, reliability of systems, effectiveness, automation, mobility, compliance with the regulations, and integration with the advanced system monitoring technologies. This kind of competition enables the companies to innovate their products and develop new technologies that help the health care sector improve the level of safety during surgeries, the efficiency of organ preservation, and the effectiveness of the transplantation process.
By introducing new innovative cardiopulmonary perfusion technologies, organ preservation technologies, and automation technologies for clinical purposes, Medtronic secures a more favorable position in the market. LivaNova strengthens its positions by developing cardiopulmonary support and perfusion systems and finding advantages over its competitors through high performance and reliability of its products. Terumo Corporation entices customers to choose its advanced cardiovascular and extracorporeal technologies which have the ability to support complicated surgeries and organ transplantation processes.
Top Companies in the Perfusion System Market
- LivaNova
- Getinge
- Medtronic
- Terumo Corporation
- Abbott Laboratories
- Fresenius Medical Care
- Xenios AG
- Braile Biomédica
- Senko Medical
- Nipro Corporation
- Eurosets
- SynCardia Systems
- Spectrum Medical
- Chalice Medical
- Tianjin Medical
Market Segmentation
The Perfusion System Market share is divided into five categories: By product type, application end user, technology and distribution channel.
The Oxygenators dominated the market, accounting for nearly 26% in 2025 and is expected to rise at a significant CAGR during the forecast period.
The Perfusion System Market is segmented by product type into Heart-Lung Machines, Perfusion Pumps, Oxygenators, Cannulae, Tubing Sets, Perfusion Monitoring Systems, Disposable Perfusion Kits, Others. Among these, the Oxygenators segment dominated the market, accounting for nearly 26% in 2025 and expected to increase at a significant CAGR during the forecast period. The Perfusion System Market was led by Oxygenators in 2025, as this segment conquered almost 26% of the market. This can be attributed to the importance of Oxygenators in ECMO and cardiopulmonary bypass processes. Growth of cardiac surgeries, presence of high demand for ECMO support, technological advancements in membrane oxygenators, and high replacement demand are some factors that will contribute to the growth of this segment during the forecast period.

The Cardiac Surgery dominated the market, accounting for nearly 42% in 2025, and is expected to rise at a significant CAGR during the forecast period.
The Perfusion System Market is segmented by application into Cardiac Surgery, Organ Transplantation, ECMO, Neurovascular Surgery, Liver Surgery, Lung Surgery, Research Applications, Others. Among these, the Cardiac Surgery segment dominated the market, accounting for nearly 42% in 2025 and expected to increase at a significant CAGR during the forecast period. The dominating segment in the Perfusion System Market in 2025 was Cardiac Surgery segment, which accounted for 42%. This is supported by the role that perfusion systems play in cardiopulmonary bypass, mainly during difficult open heart surgeries. The segment is expected to continue growing due to the surge in cardiovascular disease prevalence, increase in cardiac surgeries, improvement in heart-lung technology, and expansion in tertiary-care infrastructure.
The Hospitals dominated the market, accounting for nearly 50% in 2025 and is expected to rise at a significant CAGR during the forecast period.
The Perfusion System Market is segmented by end user into Hospitals, Cardiac Centers, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes, Academic Hospitals, Others Among these, the Hospitals segment dominated the market, accounting for nearly 50% in 2025 and expected to increase at a significant CAGR during the forecast period. In 2025, the Hospitals segment exhibited dominance in the Perfusion System Market with a share of almost 50%. This can be attributed to the extensive number of cardiac, organ transplant, and critical care surgeries performed in hospitals. Anticipated rise in investments in healthcare infrastructure, new advancements in surgeries, and the increasing acceptance of new perfusion technologies are projected to propel the growth of this segment in the coming years.
Regional Segment Analysis of the Perfusion System Market:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is the fastest-growing region in the Perfusion System Market during the period, holding almost35%share.
North America is expected to grow at a rapid CAGR in the Perfusion System Market holding almost 35% share during the forecast period. North America has the biggest share (nearly 35%) of the Perfusion Systems Market due to its advanced healthcare infrastructure, high number of cardiac surgeries and organ transplants, advanced reimbursement policies, and innovative technologies for perfusion systems processes. Moreover, the region enjoys the presence of various leading manufacturers and specialized centers in organ transplants.
Europe is expected to grow at a rapid CAGR in thePerfusion System Market, holding almost20%of the share during the forecast period.
Europe is expected to grow at a rapid CAGR in the Perfusion System Market holding almost 20% share during the forecast period. Europe is anticipated to witness a soaring CAGR growth in the Perfusion System Market due to many elements such as increased organ transplant operations, growing incidences of cardiovascular and respiratory disorders, availability of world-class healthcare infrastructure, and rising use of machine perfusion technologies. The existence of strong transplant networks along with regulatory support and financial support for advanced organ preservation technologies are also facilitating regional market progress.
Asia Pacific is the fastest-growing region in the Perfusion System Market during the period, holding roughly15%share.
Asia Pacific is the fastest-growing region in the Perfusion System Market during the forecast period, holding roughly 15%share during the forecast period. Asia Pacific has emerged as the region with the biggest growth within the Perfusion System Market, driven by improved healthcare infrastructure, the rising rate of cardiovascular disorders, increasing organ transplants, and the expanded usage of advanced machine perfusion technologies. Investments in hospitals of tertiary care level of operations, the capability to perform transplantation procedures and modern innovations in medicine in China, India, Japan and South Korea are speeding up regional growth, as well.
Strategies for Market Growth in Non-Leading Regions:
By creating efficient and scalable perfusion system solutions, it is possible to ensure the development of non-leading regions and their local healthcare institutions, research institutes, and manufacturers of biopharmaceuticals. Manufacturing, assembling, and servicing perfusion systems locally, as well as building regional centers of production and technical maintenance, would lead to decreased dependence on imports and minimized costs of investments into equipment overall, and operations in particular. The development of strategic partnerships with regional hospitals, biotechnology companies, pharmaceutical manufacturers, research organizations, and medical distributors will lead to market penetration improvement for perfusion systems producers. At the same time, in order to improve knowledge of perfusion technologies from the point of view of system functioning, process optimization, quality control, and maintenance, it will be necessary to organize special programs of training and enhancement of technical skills. Additionally, flexible financing, long-term supply agreements, leasing arrangements, and contract manufacturing will allow making perfusion systems more available, thus cooperating. The collaboration between the programs of the government healthcare sector, governments’ biotechnology initiatives and pharmaceutical research as well as by the support of medical entities together with the usage of the methods of digital sales, will lead to enhanced access to perfusion systems and sustainable market growth in emerging markets.
Future Market Trends for the Perfusion System Market: -
1.Normothermic Machine Perfusion (NMP): Moving away from the conventional cold storage of organs towards warm, near-physiological perfusion that can allow evaluation of organ viability at the time of the transplantation.
2.Artificial Intelligence and Real Time Analytics: Engaging Artificial Intelligence for monitoring perfusion parameters to find out organ viability and reducing the count of discarded donor organs.
3.Portable/Compact Systems: Developing lightweight, customizable transport perfusion devices (for example, the heart and liver transporters) to facilitate organs’ transportation in a wider area.
4.Smart automation: Introduction of the machine systems to control blood flow, pressure, and gas exchange with minimum human factor involvement.
Recent Development
- In January 2026: Bridge to Life Ltd. has attained De Novo approval from the U.S. FDA for its hypo-oxygenated VitaSmart™ oxygenated perfusion system, which means it has become the first company in the U.S. to receive such an approval for a device used in the hypothermic oxygenated perfusion of donor organs. The approval allows for the commercial application of these systems after static cold storage and before being used in transplantation. The systems' approval will also enhance the use of advanced organ preservation technologies in the perfusion system market.
- In March 2026: The first organ transplant center in the United States to make use of Bridge to Life’s Vitamart HOPE system in a clinical setting was Duke University Hospital, where a donor liver was preserved before transplantation. After getting the approval from the FDA, this development is an evidence of the increasing implementation of sophisticated techniques of organ preservation and development of the Perfusion System Market.
- In May 2026: Clinical trial results that validated hypothermic oxygenated perfusion (HOPE) in liver transplant procedures involving extended-criteria donors were published in JAMA Surgery in May 2026. The study results showed how the VitaSmart™ Perfusion System has the potential to increase donor organ usage and enhance the outcomes of transplantation. In August of the same year, Bridge to Life raised USD 110 million to fund the commercialization of VitaSmart™, develop more clinical and commercial operations, and enhance the company’s organ preservation technology portfolio.
Market Segment
This study forecasts revenue at regional and country levels from 2020 to 2033. Transpire Insights has segmented the Perfusion System Market based on the below-mentioned segments:
Perfusion System Market, By Product Type
- Heart-Lung Machines
- Perfusion Pumps
- Oxygenators
- Cannulae
- Tubing Sets
- Perfusion Monitoring Systems
- Disposable Perfusion Kits
- Others
Perfusion System Market, By Application
- Cardiac Surgery
- Organ Transplantation
- ECMO
- Neurovascular Surgery
- Liver Surgery
- Lung Surgery
- Research Applications
- Others
Perfusion System Market, By End User
- Hospitals
- Cardiac Centers
- Specialty Clinics
- Ambulatory Surgical Centers
- Research Institutes
- Academic Hospitals
- Others
Perfusion System Market, By Technology
- Conventional Perfusion
- Miniaturized Perfusion Systems
- AI-assisted Perfusion
- Automated Perfusion Systems
- Portable Perfusion Systems
- ECMO Integration
- Others
Perfusion System Market, By Distribution Channel
- Direct Sales
- Medical Device Distributors
- Hospital Procurement
- OEM Supply
- Online B2B
- Others
Perfusion System Market, By Regional Analysis
North America
- United States
- Canada
- Mexico
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia Pacific
- Japan
- China
- Australia & New Zealand
- South Korea
- India
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Rest of South America
Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of the Middle East & Africa
Frequently Asked Questions
Find quick answers to common questions.
Rising cardiac surgeries, organ transplantation, advanced machine perfusion technologies, healthcare investments, and increasing adoption of automated systems are driving market growth.
Oxygenators dominated in 2025, accounting for nearly 26%, driven by extensive use in cardiopulmonary bypass and ECMO procedures.
Cardiac Surgery dominated in 2025, accounting for nearly 42%, supported by increasing cardiovascular disease prevalence and growing surgical volumes.
Asia Pacific is expected to grow fastest, supported by healthcare infrastructure development, rising transplantation, cardiovascular diseases, and advanced perfusion technology adoption.
The Perfusion System Market is projected to reach USD 2.62 billion by 2033, expanding significantly during the forecast period.
- LivaNova
- Getinge
- Medtronic
- Terumo Corporation
- Abbott Laboratories
- Fresenius Medical Care
- Xenios AG
- Braile Biomédica
- Senko Medical
- Nipro Corporation
- Eurosets
- SynCardia Systems
- Spectrum Medical
- Chalice Medical
- Tianjin Medical
Recently Published Reports
-
Apr 2026
AI in Diabetic Retinopathy Market
AI in Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Screening AI Systems, Diagnostic AI Systems, and Predictive AI Models), By Application Segment (Hospitals, Ophthalmology Clinics, Diagnostic Centers, and Research and Development), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 - 2031
-
Apr 2026
Psychometric Tests Market
Psychometric Tests Market Size, Share & Analysis Report By Type (Personality Tests, Ability/Aptitude Tests, Skill/Knowledge Tests, and Others), By Application (Talent Acquisition and Talent Management), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Apr 2026
Rare Biological Sample Collection Market
Rare Biological Sample Collection Market Size, Share & Analysis Report By Type (Isolation Kits & Reagent, Blood Collection Tubes, and Others), By Application (Oncology, Transcriptomics, Pharmacogenomics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
-
Jul 2026
Diabetic Retinopathy Market
Diabetic Retinopathy Market Size, Share & Analysis Report By Type (Proliferative Diabetic Retinopathy, and Diabetic Macular Edema (DME)), By Treatment Type (Anti VEGF Drug, Steroid Implants, Laser Surgeries, and Vitrectomy), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South and Central America), 2021 – 2031
Our Clients
.jpg)








